[Treatment in the patient with hepatic encephalopathy and coma].
D000777:Anesthetics / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001923:Brain Chemistry; D001971:Bromocriptine / Q000627:therapeutic use; D002241:Carbohydrates / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004733:Enema; D006471:Gastrointestinal Hemorrhage / Q000150:complications; D006501:Hepatic Encephalopathy / Q000209:etiology / Q000378:metabolism / Q000628:therapy*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007980:Levodopa / Q000627:therapeutic use; D018377:Neurotransmitter Agents / Q000378:metabolism; D014883:Water-Electrolyte Imbalance / Q000150:complications
D000777:Anesthetics; D000900:Anti-Bacterial Agents; D002241:Carbohydrates; D006993:Hypnotics and Sedatives; D018377:Neurotransmitter Agents; D001971:Bromocriptine; D007980:Levodopa
Tratamiento en el paciente con encefalopatía y coma hepático.